Troluce Capital Advisors LLC Buys 623,655 Shares of R1 RCM Inc. (NASDAQ:RCM)

Troluce Capital Advisors LLC boosted its position in R1 RCM Inc. (NASDAQ:RCM) by 373.7% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 790,555 shares of the healthcare provider’s stock after purchasing an additional 623,655 shares during the quarter. R1 RCM makes up approximately 1.0% of Troluce Capital Advisors LLC’s investment portfolio, making the stock its 24th largest holding. Troluce Capital Advisors LLC owned about 0.19% of R1 RCM worth $9,929,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Charles Schwab Investment Management Inc. raised its holdings in shares of R1 RCM by 1.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,192,722 shares of the healthcare provider’s stock worth $12,607,000 after buying an additional 21,447 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of R1 RCM by 81.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,826,545 shares of the healthcare provider’s stock valued at $29,879,000 after acquiring an additional 1,269,837 shares during the period. Principal Financial Group Inc. raised its stake in R1 RCM by 2.7% in the 4th quarter. Principal Financial Group Inc. now owns 810,025 shares of the healthcare provider’s stock worth $8,562,000 after acquiring an additional 21,526 shares during the last quarter. Norges Bank acquired a new stake in R1 RCM during the 4th quarter worth about $42,539,000. Finally, Hsbc Holdings PLC grew its stake in R1 RCM by 24.6% during the 4th quarter. Hsbc Holdings PLC now owns 355,700 shares of the healthcare provider’s stock valued at $3,764,000 after purchasing an additional 70,203 shares during the last quarter. 61.10% of the stock is owned by hedge funds and other institutional investors.

R1 RCM Stock Performance

NASDAQ:RCM opened at $14.15 on Wednesday. The company has a market cap of $5.96 billion, a P/E ratio of -176.88 and a beta of 0.84. R1 RCM Inc. has a twelve month low of $8.87 and a twelve month high of $15.82. The company’s 50-day moving average price is $13.84 and its 200-day moving average price is $13.00. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.77.

R1 RCM (NASDAQ:RCM) last released its earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.03. The business had revenue of $627.90 million for the quarter, compared to analyst estimates of $633.10 million. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The firm’s revenue for the quarter was up 12.0% compared to the same quarter last year. On average, sell-side analysts forecast that R1 RCM Inc. will post -0.24 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Leerink Partnrs lowered R1 RCM from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $19.00 price objective on shares of R1 RCM in a report on Friday, June 28th. Morgan Stanley cut shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 8th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $14.30 price target on shares of R1 RCM in a report on Tuesday, August 20th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and set a $15.00 price target on shares of R1 RCM in a research report on Monday, July 22nd. Thirteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $15.41.

R1 RCM Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.